40 related articles for article (PubMed ID: 8832032)
21. Mixed chimerism after allogeneic marrow transplantation.
Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
[No Abstract] [Full Text] [Related]
22. Pediatric bone marrow transplantation.
Chan KW
Pediatr Dent; 1995; 17(4):291-3. PubMed ID: 7567633
[No Abstract] [Full Text] [Related]
23. Acute myeloid leukemia following solid organ transplantation: case report and comprehensive review.
Kourelis TV; Boruchov A; Hull D; Polio J; Scholes J; Moustakakis M; Bilgrami SF
Conn Med; 2012 Mar; 76(3):151-4. PubMed ID: 22666974
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.
Boiron JM; Cony-Makhoul P; Mahon FX; Pigneux A; Puntous M; Reiffers J
Blood Rev; 1994 Dec; 8(4):234-40. PubMed ID: 7888830
[TBL] [Abstract][Full Text] [Related]
25. Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.
Alten J; Klapper W; Leuschner I; Eckert C; Beier R; Vallo E; Krause M; Claviez A; Vieth S; Bleckmann K; Möricke A; Schrappe M; Cario G
Pediatr Blood Cancer; 2015 Sep; 62(9):1656-60. PubMed ID: 25833113
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions.
Vandenberghe P; Boogaerts MA
Ann Hematol; 1995 Nov; 71(5):209-17. PubMed ID: 7492623
[No Abstract] [Full Text] [Related]
27. [Minimal residual disease].
Francia di Celle P; Foà R
Haematologica; 1991 Jun; 76 Suppl 3():303-10. PubMed ID: 1752527
[No Abstract] [Full Text] [Related]
28. [Bone marrow transplantation in oncology].
Tiuliandin SA
Vopr Onkol; 1991; 37(3):259-65. PubMed ID: 2031319
[No Abstract] [Full Text] [Related]
29. Donor leukocyte transfusions for leukemic relapse.
van Rhee F; Kolb HJ
Curr Opin Hematol; 1995 Nov; 2(6):423-30. PubMed ID: 9372031
[TBL] [Abstract][Full Text] [Related]
30. Leukemia and the regulation of hematopoiesis.
Nathan DG
Leukemia; 1987 Oct; 1(10):683-96. PubMed ID: 3312832
[No Abstract] [Full Text] [Related]
31. Precursor lymphoblastic lymphoma reoccurring as a donor-derived neoplasm: a case report and review of the literature.
Dickson BC; Chung CT; Patterson BJ; Riddell RH; Kamel-Reid S; Messner HA; Lipton JH
Arch Pathol Lab Med; 2008 Aug; 132(8):1342-5. PubMed ID: 18684038
[TBL] [Abstract][Full Text] [Related]
32. Donor leukocyte infusions for relapsed leukemia after allogeneic BMT.
Mackinnon S
Hematol Cell Ther; 1996 Oct; 38(5):461-2. PubMed ID: 8915673
[No Abstract] [Full Text] [Related]
33. Leukemia relapse after allogeneic bone marrow transplantation: a review.
Giralt SA; Champlin RE
Blood; 1994 Dec; 84(11):3603-12. PubMed ID: 7949117
[No Abstract] [Full Text] [Related]
34. Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.
Sumi M; Kitahara M; Shishido T; Kazumoto H; Uematsu N; Kirihara T; Sato K; Ueki T; Hiroshima Y; Shimizu K; Kobayashi H
Intern Med; 2020 Jan; 59(1):113-118. PubMed ID: 31462594
[TBL] [Abstract][Full Text] [Related]
35. New frontiers for allogeneic bone marrow transplantation.
Marmont AM
Bone Marrow Transplant; 1993; 11 Suppl 1():3-10. PubMed ID: 8448541
[No Abstract] [Full Text] [Related]
36. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
[TBL] [Abstract][Full Text] [Related]
37. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
[TBL] [Abstract][Full Text] [Related]
39. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
